The dark side of using AI to design drugs | Curio
News and insights read out for you.
10,000+ audio articles. 50+ world-leading publications.

All in 1 subscription.

Financial Times logo

The dark side of using AI to design drugs

5 mins | Mar 23, 2022
story image
How did this simple experiment produce such chilling results? An AI began with a set of molecules, including pesticides and instructions to reward toxicity while penalising any therapeutic activity. And within six hours, it had produced 40,000 killer molecules, including the nerve agent VX, responsible for the assassination of Kim Jong Un's half brother. In the wake of these startling results, Anjana Ahuja discovers how a team at Collaborations Pharmaceuticals repurposed this life-saving technology to design biochemical weapons and unmasked the dark side of AI.
Get unlimited access free for 7 days, then $6.67/month (billed annually)
Get started